Parallel Advisors’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-510
Closed -$26.2K 3318
2023
Q4
$26.2K Hold
510
﹤0.01% 1774
2023
Q3
$29.5K Hold
510
﹤0.01% 1653
2023
Q2
$22.6K Hold
510
﹤0.01% 1791
2023
Q1
$25.8K Hold
510
﹤0.01% 1707
2022
Q4
$31.2K Hold
510
﹤0.01% 1504
2022
Q3
$35K Hold
510
﹤0.01% 1415
2022
Q2
$40K Hold
510
﹤0.01% 1355
2022
Q1
$78K Buy
+510
New +$75.7K ﹤0.01% 1082

Other funds holding CNBS

Parallel Advisors's CNBS Position: Q1 2024 in Review

Parallel Advisors sold out of Amplify Seymour Cannabis ETF (CNBS) in Q1 2024, closing a stake of 510 shares — an estimated $26.2K sold.

Parallel Advisors first reported a position in CNBS in Q1 2022 and held it in 8 quarters. The position peaked at $78K in Q1 2022. 27 funds tracked by Wall St. Rank hold CNBS as of Q1 2024.

  • Parallel Advisors reported no remaining Amplify Seymour Cannabis ETF position as of Q1 2024 after selling out during the quarter.
  • Parallel Advisors sold 510 Amplify Seymour Cannabis ETF shares in Q1 2024, an estimated $26.2K.
  • Parallel Advisors first reported a position in Amplify Seymour Cannabis ETF in Q1 2022 and held it in 8 quarters.
  • Parallel Advisors's Amplify Seymour Cannabis ETF position peaked at $78K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q1 2024.

Based on Parallel Advisors's 13F filing for Q1 2024, filed 6 May 2024.